Has Erin Debiasi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $9,605 in general payments to Erin Debiasi, MD across 20 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Erin Debiasi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Erin Debiasi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Erin Debiasi, MD

Pulmonary Disease · New Haven, CTNPI 1750601225

Payments from drug & device makers

What this record shows

This record is dominated by education: $7,250 of the $9,605 with a category attached, or 75.5%. Intuitive Surgical accounts for 85.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $7,187 and has fallen 81.1% since, to $1,359 in 2025.

$9,605in general payments, 2019–2025

Across 20 payments — averaging $480.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$8K
Pulmonx Corporation$715
Johnson & Johnson$507
Olympus America Inc.$109
Boston Scientific$68
Amgen$14

What the payments were for

Speaking & faculty fees$5005%
Travel & lodging$1,47415%
Food & beverage$3814%
Education$7,25075%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	10	$8,192
Pulmonx Corporation	3	$715
Johnson & Johnson	2	$507
Olympus America Inc.	2	$109
Boston Scientific	2	$68
Amgen	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,605 in reported general payments places this provider in the 80th percentile of 255 pulmonary disease providers in Connecticut.

See all pulmonary disease providers in Connecticut →

Medicare billing

Part B allowed, 2024

$59,937

Medicare patients

189

Services billed

511

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in New Haven

Geoffrey ChuppNew Haven$1.2M
Michael ImevboreNew Haven$323K
Naftali KaminskiNew Haven$180K
Lauren CohnNew Haven$134K
Erica HerzogNew Haven$74K
Mridu GulatiNew Haven$53K
Jennifer PossickNew Haven$48K
Carolyn RochesterNew Haven$29K
Maor SaulerNew Haven$18K
Jonathan KoffNew Haven$15K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →